Jeffrey L. Saver

104.1k total citations · 22 hit papers
842 papers, 54.3k citations indexed

About

Jeffrey L. Saver is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Jeffrey L. Saver has authored 842 papers receiving a total of 54.3k indexed citations (citations by other indexed papers that have themselves been cited), including 662 papers in Epidemiology, 348 papers in Pulmonary and Respiratory Medicine and 257 papers in Neurology. Recurrent topics in Jeffrey L. Saver's work include Acute Ischemic Stroke Management (656 papers), Cerebrovascular and Carotid Artery Diseases (318 papers) and Stroke Rehabilitation and Recovery (222 papers). Jeffrey L. Saver is often cited by papers focused on Acute Ischemic Stroke Management (656 papers), Cerebrovascular and Carotid Artery Diseases (318 papers) and Stroke Rehabilitation and Recovery (222 papers). Jeffrey L. Saver collaborates with scholars based in United States, Canada and Australia. Jeffrey L. Saver's co-authors include Chelsea S. Kidwell, Sidney Starkman, David S. Liebeskind, Bruce Ovbiagele, Reza Jahan, Lee H. Schwamm, Edward C. Jauch, Gregg C. Fonarow, Eric E. Smith and Jeffry R. Alger and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jeffrey L. Saver

800 papers receiving 52.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

2013 5.9k citations Edward C. Jauch, Jeffrey L. Saver et al. Stroke profile →
Time Is Brain—Quantified

2005 1.4k citations Jeffrey L. Saver Stroke profile →
Definition and Evaluation of Transient Ischemic Attack

2009 1.2k citations Jeffrey L. Saver, Randall T. Higashida et al. Stroke profile →
The Impact of Recanalization on Ischemic Stroke Outcome

2007 1.1k citations Jeffrey L. Saver et al. Stroke profile →
Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke

2005 954 citations Sidney Starkman, Jeffrey L. Saver et al. Stroke profile →
Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial

2012 943 citations Jeffrey L. Saver, Reza Jahan et al. profile →
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke

2013 931 citations Reza Jahan, Lee H. Schwamm et al. profile →
Mechanical Thrombectomy for Acute Ischemic Stroke

2008 911 citations Jeffrey L. Saver, David S. Liebeskind et al. Stroke profile →
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke

2017 629 citations Jeffrey L. Saver et al. profile →
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke

2013 606 citations Jeffrey L. Saver et al. profile →
Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

2009 598 citations Jeffrey L. Saver, Edward C. Jauch et al. Stroke profile →
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke

2013 583 citations Jeffrey L. Saver, Gregg C. Fonarow et al. profile →
Forecasting the Future of Stroke in the United States

2013 577 citations Bruce Ovbiagele, Larry B. Goldstein et al. Stroke profile →
Transient Ischemic Attack — Proposal for a New Definition

2002 550 citations Jeffrey L. Saver et al. profile →
Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging

2000 504 citations Jeffrey L. Saver, Sidney Starkman et al. profile →
Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke

2011 455 citations Gregg C. Fonarow, Eric E. Smith et al. profile →
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke

2015 442 citations James C. Grotta, Shyam Prabhakaran et al. Stroke profile →
Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

2014 407 citations Gregg C. Fonarow, Eric E. Smith et al. profile →
Collateral Flow Predicts Response to Endovascular Therapy for Acute Ischemic Stroke

2011 396 citations Jeffrey L. Saver, Bruce Ovbiagele et al. Stroke profile →
Ischemic Strokes Due to Large-Vessel Occlusions Contribute Disproportionately to Stroke-Related Dependence and Death: A Review

2017 261 citations Jeffrey L. Saver et al. Frontiers in Neurology profile →
eTICI reperfusion: defining success in endovascular stroke therapy

2018 249 citations Reza Jahan, Bijoy K. Menon et al. Journal of NeuroInterventional Surgery profile →
Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice

2019 226 citations Reza Jahan, Jeffrey L. Saver et al. profile →

Peers

Countries citing papers authored by Jeffrey L. Saver

Since Specialization

Citations

This map shows the geographic impact of Jeffrey L. Saver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Saver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Saver more than expected).

Fields of papers citing papers by Jeffrey L. Saver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Saver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Saver. The network helps show where Jeffrey L. Saver may publish in the future.

Co-authorship network of co-authors of Jeffrey L. Saver

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey L. Saver. A scholar is included among the top collaborators of Jeffrey L. Saver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey L. Saver. Jeffrey L. Saver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patent Foramen Ovale–Associated Stroke 2024 ·Cardiology Clinics ·Jeffrey L. Saver	0
2	The National Institutes of Health Stroke Scale is comparable to the ICH score in predicting outcomes in spontaneous acute intracerebral hemorrhage 2024 ·Frontiers in Neurology ·(unknown), Kristina Shkirkova, Jeffrey L. Saver, David S. Liebeskind, Sidney Starkman, (unknown), R Poblete, May Kim‐Tenser, (unknown), Robin Conwit, Pablo Villablanca, Scott Hamilton, Nerses Sanossian	4
3	Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention 2023 ·JAMA Neurology ·Chia‐Yu Hsu, Jeffrey L. Saver, Bruce Ovbiagele, Yi‐Ling Wu, Chun-Yu Cheng, Meng Lee	13
4	Effect of Magnesium on Deterioration and Symptomatic Hemorrhagic Transformation in Cerebral Ischemia: An Ancillary Analysis of the FAST-MAG Trial 2023 ·Cerebrovascular Diseases ·(unknown), (unknown), May Kim‐Tenser, Kristina Shkirkova, David S. Liebeskind, Sidney Starkman, J. Pablo Villablanca, Scott Hamilton, Andrew M. Naidech, Jeffrey L. Saver, Nerses Sanossian, (unknown)	0
5	Association of the time of day of EVT with clinical outcomes and benefit from successful recanalization after stroke 2023 ·Annals of Clinical and Translational Neurology ·(unknown), (unknown), (unknown), Fanny Quandt, Hanna Zimmermann, (unknown), Lars Kellert, Thomas Liebig, Konstantinos Dimitriadis, Jeffrey L. Saver, Steffen Tiedt, (unknown)	6
6	Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities 2023 ·BMC Neurology ·(unknown), (unknown), Pamela W. Duncan, Steven C. Cramer, Mersedeh Bahr Hosseini, Michael Su, Sidney Starkman, (unknown), (unknown), Scott Hamilton, Robin Conwit, Jeffrey L. Saver	1
7	EMAGINE–Study protocol of a randomized controlled trial for determining the efficacy of a frequency tuned electromagnetic field treatment in facilitating recovery within the subacute phase following ischemic stroke 2023 ·Frontiers in Neurology ·Jeffrey L. Saver, Pamela W. Duncan, Joel Stein, Steven C. Cramer, Janice J. Eng, (unknown), (unknown), Natan M. Bornstein	1
8	Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial 2023 ·BMJ Neurology Open ·Lisa J Woodhouse, Jason P. Appleton, Sandeep Ankolekar, Timothy J. England, Grant Mair, Keith W. Muir, Christopher Price, Stuart Pocock, Marc Randall, Thompson Robinson, Christine Roffe, Else Charlotte Sandset, Jeffrey L. Saver, A Niroshan Siriwardena, Nikola Sprigg, Joanna M. Wardlaw, Philip M. Bath	0
9	Impact of Hyperglycemia According to the Collateral Status on Outcomes in Mechanical Thrombectomy 2018 ·Stroke ·Joon‐Tae Kim, David S. Liebeskind, Reza Jahan, Bijoy K. Menon, Mayank Goyal, Raul G. Nogueira, Vítor Mendes Pereira, Jan Gralla, Jeffrey L. Saver	51
10	Pioglitazone for Secondary Stroke Prevention 2016 ·Stroke ·Meng Lee, Jeffrey L. Saver, Hung‐Wei Liao, Chun-Hsien Lin, Bruce Ovbiagele	98
11	Stroke Thrombolysis 2014 ·Stroke ·Atte Meretoja, Mahsa Keshtkaran, Jeffrey L. Saver, Turgut Tatlisumak, Mark Parsons, Markku Kaste, Stephen M. Davis, Geoffrey A. Donnan, Leonid Churilov	236
12	Forecasting the Future of Stroke in the United States breakdown → 2013 ·Stroke ·Bruce Ovbiagele, Larry B. Goldstein, Randall T. Higashida, Virginia J. Howard, S. Claiborne Johnston, Olga Khavjou, Daniel T. Lackland, Judith H. Lichtman, (unknown), Ralph L. Sacco, Jeffrey L. Saver, Justin G. Trogdon	577
13	Importance of proper patient selection and endpoint selection in evaluation of new therapies in acute stroke: further analysis of the SENTIS trial 2013 ·Journal of NeuroInterventional Surgery ·Ashfaq Shuaib, Stefan Schwab, J. Neal Rutledge, Sidney Starkman, David S. Liebeskind, Gary L. Bernardini, Alan S. Boulos, Alex Abou‐Chebl, David Huang, Geert Vanhooren, Salvador Cruz‐Flores, Richard Klucznik, Jeffrey L. Saver, (unknown)	17
14	Risk-Benefit Profile of Warfarin Versus Aspirin in Patients With Heart Failure and Sinus Rhythm 2012 ·Circulation Heart Failure ·Meng Lee, Jeffrey L. Saver, Keun‐Sik Hong, (unknown), Bruce Ovbiagele	17
15	Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator 2012 ·Stroke ·Bijoy K. Menon, Jeffrey L. Saver, Shyam Prabhakaran, Mathew J. Reeves, Li Liang, DaiWai M. Olson, Eric D. Peterson, Adrian F. Hernandez, Gregg C. Fonarow, Lee H. Schwamm, Eric E. Smith	191
16	Efficacy of Intra-Arterial Fibrinolysis for Acute Ischemic Stroke 2010 ·Stroke ·Meng Lee, Keun‐Sik Hong, Jeffrey L. Saver	100
17	Collateral Circulation in Symptomatic Intracranial Atherosclerosis 2010 ·Journal of Cerebral Blood Flow & Metabolism ·David S. Liebeskind, George Cotsonis, Jeffrey L. Saver, Michael Lynn, Harry J. Cloft, Marc I. Chimowitz, (unknown)	100
18	Identifying Patients at High Risk for Poor Outcome After Intra-Arterial Therapy for Acute Ischemic Stroke 2009 ·Stroke ·Hen Hallevi, Andrew D. Barreto, David S. Liebeskind, Miriam M. Morales, Sheryl Martin‐Schild, Anitha Abraham, (unknown), Jeffrey L. Saver, (unknown), James C. Grotta, Sean I. Savitz	104
19	Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale 2009 ·Stroke ·Maarten G. Lansberg, Maarten Schrooten, Erich Bluhmki, Vincent Thijs, Jeffrey L. Saver	152
20	Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke 2008 ·Stroke ·Daniel T. Laskowitz, Scott E. Kasner, Jeffrey L. Saver, Kerri Remmel, Edward C. Jauch, (unknown)	159

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact